Dose, Schedule, Safety, and Efficacy of Guadecitabine in Relapsed or Refractory Acute Myeloid Leukemia

Roboz, GJ; Kantarjian, HM; Yee, KWL; Kropf, PL; O'Connell, CL; Griffiths, EA; Stock, W; Daver, NG; Jabbour, E; Ritchie, EK; Walsh, KJ; Rizzieri, D; Lunin, SD; Curio, T; Chung, W; Hao, Y; Lowder, JN; Azab, M; Issa, JPJ

Roboz, GJ (reprint author), NewYork Presbyterian Hosp, 520 East 70th St, New York, NY 10021 USA.

CANCER, 2018; 124 (2): 325

Abstract

BACKGROUND: Outcomes for patients with relapsed or refractory acute myeloid leukemia (AML) are poor. Guadecitabine, a next-generation hypomethylating ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索